CureVac’s COVID-19 vaccine shows immune response in Phase 1 trial

German biotech CureVac said advanced clinical trials are on track to launch by the end of 2020.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.